BioScience Health Innovations, Inc.
BHIC
$4.49
$0.4912.25%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 38.02% | -52.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 38.02% | -52.26% | |||
| Cost of Revenue | 42.01% | -73.48% | |||
| Gross Profit | 35.81% | -15.09% | |||
| SG&A Expenses | 22.63% | -1.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.86% | -43.28% | |||
| Operating Income | 5.22% | -46.71% | |||
| Income Before Tax | 5.22% | -46.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.18% | 1.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.18% | 1.58% | |||
| EBIT | 5.22% | -46.71% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 21.29% | 5.16% | |||
| Normalized Basic EPS | 7.14% | -41.57% | |||
| EPS Diluted | 0.99% | 5.16% | |||
| Normalized Diluted EPS | 7.14% | -41.57% | |||
| Average Basic Shares Outstanding | 2.70% | 3.62% | |||
| Average Diluted Shares Outstanding | 2.70% | 3.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||